Wu: Usually, patients need therapy three times a week for the first eight to 12 weeks, which is called the induction phase. How do you suggest they use the device?ĭr. Unfortunately, it’s not available for out-of-pocket purchase. It is available for Medicare & Tricare beneficiaries (for the treatment of psoriasis) and members of health plans and self-insured employers which cover the Zerigo Health Solution as part of their health benefits program. Patients also appreciate not having to come to the clinic for follow-up visits. During the COVID-19 pandemic, this has been my recommended method of phototherapy. Patients who prefer to have their phototherapy at home, live far from the clinic, or have a busy work or school schedule benefit from it. Patients who are tech-savvy tend to prefer this type of self-delivered care, but all patients can benefit from using this treatment model. The ideal patients present with three percent to 10 percent affected body surface area. Wu: I recommend Zerigo for mild to moderate psoriasis more than other conditions. Which patients benefit most from the device?ĭr. They also use this real-time treatment data to monitor all patients on therapy and provide them with personal coaching and support to help them throughout their treatment journey. Zerigo has a group called CarePartners who are trained phototherapy experts and care coordinators.
#Sente dermal repair cream ultra nourish software
All the treatment, adherence, and patient-reported outcomes data are then aggregated and analyzed in Zerigo’s cloud-based software application and condensed into summary progress reports to monitor patient progress, counsel patients during follow-up visits, and monitor for side effects.
The handheld Narrowband UVB (NB-UVB) phototherapy treatment device plus the patient’s mobile phone help manage dosing, treatment frequency, and duration of therapy, according to the prescription. Wu, MD: Zerigo Health’s connected home phototherapy treatment platform (Zerigo Health Solution) is cleared for psoriasis.
0 kommentar(er)
